InfaCare is backed by an premier group of venture capital firms. The Company was initially founded by WellSpring Pharmaceutical Corporation and funded by "angel" investors. In March 2006, InfaCare closed a $12 million Series A financing, and in October 2008 closed a $28 million Series B financing. The principal investors in InfaCare are:
Atlas Venture is a leading early-stage international venture capital firm that invests in technology and life sciences businesses in the US and Europe. Since inception in 1980, its partners have helped build over 350 companies in more than 16 different countries. In the past decade, 44 portfolio companies have been acquired and 47 are now public companies with an aggregate market capitalization of over $15 billion. Atlas Venture manages over $2.5 billion in capital through offices in Boston and London.
FirstMark Capital, with nearly $2.0 billion in capital commitments and approximately $1.0 billion in capital under management, is focused on today's most dynamic and innovative technology companies. For more than a decade, FirstMark has partnered with talented entrepreneurs and experienced managers to build market-leading companies. FirstMark is located in New York City.
HealthCare Ventures is a leading venture capital firm specializing in life science industry HealthCare Ventures is a leading venture capital firm specializing in life science companies showing high growth potential. Since 1985, HealthCare Ventures has raised $1.6 billion in eight funds, and invested in a total of 97 companies, primarily early-stage. Of those companies, 22 have become public and 24 have been acquired by or merged into public companies. Offices are located in Cambridge, MA and Princeton, NJ.
Founded in 2006, Longitude Capital is a venture capital firm that invests in medical device and biotechnology companies developing products that address important unmet medical or economic needs in the life sciences industry. Longitude's investment team has more than 100 years of industry experience and has invested in over 100 life sciences companies. Their inaugural fund, the $325,000,000 Longitude Venture Partners, L.P., was closed in 2008. Our offices are located in Menlo Park, CA and Greenwich, CT.